Skip to content
← Myeloproliferative Neoplasms

FOR PATIENTS · SOURCE READING

Certain factors affect prognosis (chance of recovery) and treatment options for essential thrombocythemia.

Source: Myeloproliferative Neoplasms Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: May 12, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Prognosis and treatment options depend on:

Source links and citations

the age of the patient

whether the patient has signs or symptoms or other problems related to essential thrombocythemia

Preserved source evidence · Independent clinical review pending · Not medical advice